Bullboard - Stock Discussion Forum Bioxytran Inc BIXT

Healthcare Biotechnology

Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with an intended application, which includes... see more

Add To Watchlist

OTCQB:BIXT - Post Discussion

Bioxytran Inc > Bioxytran, Inc. ($BIXT): Leading Healthcare Innovation!

View:

Post by amritadanique on Oct 27, 2023 8:02am

Bioxytran, Inc. ($BIXT): Leading Healthcare Innovation!

Bioxytran, Inc. ($BIXT) boasts a market capitalization of $21.74 million and a strong 30-day average volume of 117,188, underscoring its presence in the healthcare landscape. As a biotech pioneer, Bioxytran is dedicated to advancing medical science by tackling critical medical challenges such as hypoxia, glycovirology, and degenerative diseases. With 144 million+ outstanding shares, Bioxytran is a key player in healthcare innovation.